EcoDrugPlus

Tubulin Alpha-1c Chain-Like

Ensembl ID : ENSDNOG00000034524
Gene Symbol: LOC101426121
3 Cross references
169 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSDNOG00000010771
Gene Symbol: TUBB1
4 Cross references
186 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSDNOG00000044521
Gene Symbol: TUBB3
2 Cross references
158 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSDNOG00000044946
Gene Symbol: TUBB4A
4 Cross references
89 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSDNOG00000040531
Gene Symbol: TUBB4B
4 Cross references
178 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSDNOG00000001779
Gene Symbol: TUBB6
4 Cross references
141 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSDNOG00000046657
Gene Symbol: TUBB
4 Cross references
257 Possible Orthologues:

Tubulin Beta-2a Chain

Ensembl ID : ENSDNOG00000010566
Gene Symbol: LOC101418816
3 Cross references
154 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSDNOG00000005252
Gene Symbol: TP53
2 Cross references
254 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSDNOG00000018729
Gene Symbol: TYR
4 Cross references
266 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSDNOG00000039883
Gene Symbol: TYK2
2 Cross references
197 Possible Orthologues:

Utrophin

Ensembl ID : ENSDNOG00000005500
Gene Symbol: UTRN
4 Cross references
268 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).